These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6608470)

  • 1. [Importance of immunological and cytochemical studies of the peripheral blood lymphocytes in myeloma patients during polychemotherapy].
    Golenkov AK; Andreeva OK; Zlatkina AR; Cheredeev AN
    Gematol Transfuziol; 1984 Feb; 29(2):19-22. PubMed ID: 6608470
    [No Abstract]   [Full Text] [Related]  

  • 2. [The characteristics of the immunological indices in multiple myeloma during polychemotherapy].
    Abdulkadyrov KM; Bessmel'tsev SS
    Lik Sprava; 1995; (3-4):75-80. PubMed ID: 8819928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytochemical and immunologic characteristics of peripheral blood lymphocytes in myeloma].
    Abramenko IV; Nadgornaia VA; Skliarenko LM; Poludnenko LIu
    Vrach Delo; 1983 Sep; (9):79-82. PubMed ID: 6606267
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple myeloma and immunomodulation: regulating the regulatory cells.
    Kasyapa CS; Sher T; Chanan-Khan AA
    Leuk Lymphoma; 2012 Jul; 53(7):1253-4. PubMed ID: 22397723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lymphocyte subpopulations of the peripheral blood in multiple myeloma patients studied by the immunocytochemical PAP method using monoclonal antibodies].
    Abramenko IV; Gluzman DF; Sverstiuk AE; Baryshnikov AIu; Filatov AV
    Gematol Transfuziol; 1988 Aug; 33(8):38-41. PubMed ID: 2461327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormality of the immunoregulatory system in multiple myeloma].
    Funato T
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1547-56. PubMed ID: 3879079
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma.
    Muthu Raja KR; Kovarova L; Hajek R
    Leuk Lymphoma; 2012 Jul; 53(7):1406-8. PubMed ID: 22200079
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal B-lymphocytes in peripheral blood of patients with plasma cell myeloma. Relation to activity of the disease.
    Mellstedt H; Pettersson D; Holm G
    Scand J Haematol; 1976 Feb; 16(2):112-20. PubMed ID: 769146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological and rheological disorders in multiple myeloma patients].
    Abdulkadyrov KM; Bessmel'tsev SS; Liubimova NIu
    Ter Arkh; 1991; 63(7):122-6. PubMed ID: 1788790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surface phenotype and suppressor function of the blood lymphocytes in multiple myeloma].
    Evsev'eva AI; Abramenko IV
    Eksp Onkol; 1984; 6(6):67-8. PubMed ID: 6241145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the peripheral blood lymphocytes stimulated by pokeweed mitogen in multiple myeloma patients].
    Evsev'eva AI; Abramenko IV
    Vrach Delo; 1987 Aug; (8):43-5. PubMed ID: 3500543
    [No Abstract]   [Full Text] [Related]  

  • 13. Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy.
    Dreyfus F; Melle J; Quarre MC; Pillier C
    Br J Haematol; 1993 Oct; 85(2):411-2. PubMed ID: 8280616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte subpopulations in the peripheral blood during polychemotherapy of non-Hodgkin's lymphoma].
    Trepińska E; Burchardt K; Sokołowski K
    Pol Tyg Lek; 1985 Aug; 40(33):932-5. PubMed ID: 3877275
    [No Abstract]   [Full Text] [Related]  

  • 15. Early B lymphocytes in man.
    Conte PF; Boccadoro M; Pileri A
    Experientia; 1980 Sep; 36(9):1124-5. PubMed ID: 6968278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological and electron microscope characteristics of peripheral blood lymphocytes in myeloma disease].
    Abramenko IB; Iurchenko OV; Skliarenko LM; Nadgornaia VA; Vetrova EP
    Eksp Onkol; 1987; 9(1):46-9, 52. PubMed ID: 3816658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status of the immune system in multiple myeloma during polychemotherapy].
    Golenkov AK; Cheredeev AN; Zlatkina AR; Konstantinpva NA; Mattes KH
    Gematol Transfuziol; 1987 Jun; 32(6):9-13. PubMed ID: 3623063
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indicators of nonspecific immunity in patients with non-Hodgkin's lymphoma of high grade malignancy in the remission phase of the disease].
    Urasiński I; Zdziarska B
    Pol Arch Med Wewn; 1991 Nov; 86(5):304-10. PubMed ID: 1726497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T- and B-lymphocytes of the peripheral blood in myeloma disease].
    Loginskiĭ VE; Kotsaĭ BR; Korotkiĭ VV
    Vrach Delo; 1978 Sep; (9):19-22. PubMed ID: 81566
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of morphological, cytochemical, immunological and clinical features of adult T cell acute lymphoblastic leukemia.
    Ferrara F; Del Vecchio L; Fasanaro A; Rametta V; Ronconi F; Montuori R
    Ric Clin Lab; 1988; 18(1):45-51. PubMed ID: 3259715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.